KZIA
Kazia Therapeutics Ltd ADR
NASDAQ: KZIA · HEALTHCARE · BIOTECHNOLOGY
$13.64
+9.82% today
Updated 2026-04-30
Market cap
$135.07M
P/E ratio
—
P/S ratio
71.14x
EPS (TTM)
$-7.61
Dividend yield
—
52W range
$3 – $17
Volume
0.2M
Kazia Therapeutics Ltd ADR (KZIA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
+96.5%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-125145.9%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-1.5%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-1.5%
2025-11-07
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-11-07 | $-7.64 | +96.5% | $7.50 | $7.39 | -1.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $-221.00 | $-7.64 | +96.5% | $19710.00 | -99.2% |
| 2025-03-31 | $0.00 | $-12.30 | — | — | — |
| 2024-09-30 | $0.00 | $-31.22 | — | $2.48M | — |
| 2021-03-31 | $0.00 | $-0.01 | — | — | — |
| 2020-12-31 | $0.00 | $-0.01 | — | — | — |
| 2020-09-30 | $0.00 | $-0.02 | — | — | — |
| 2020-06-30 | $0.00 | $-0.02 | — | — | — |
| 2020-03-31 | $0.00 | $-0.03 | — | — | — |
| 2019-12-31 | $0.00 | $-0.03 | — | — | — |
| 2019-09-30 | $0.00 | $-0.03 | — | — | — |
| 2019-06-30 | $0.00 | $-0.03 | — | — | — |
| 2019-03-31 | $0.00 | $-0.02 | — | — | — |
| 2018-12-31 | $0.00 | $-0.02 | — | — | — |
Frequently asked questions
Has Kazia Therapeutics Ltd ADR beaten earnings estimates?
Kazia Therapeutics Ltd ADR has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of +96.5% over the last 1 quarters.
How does KZIA stock react to earnings?
KZIA stock has moved an average of -1.5% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.